{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T23:45:16Z","timestamp":1791762316229,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100019949","name":"FUJIFILM Toyama Chemical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Nontypeable\n                      <jats:italic>Haemophilus influenzae<\/jats:italic>\n                      (NTHi) and\n                      <jats:italic>Moraxella catarrhalis<\/jats:italic>\n                      are recognized as the key pathogens that cause respiratory tract infections, and both are capable of forming biofilms. Although interspecies biofilm formation has been described, the impact of co-culture conditions on antimicrobial responsiveness remains incompletely defined. In this study, we examined biofilm formation by co-culturing NTHi and\n                      <jats:italic>M. catarrhalis<\/jats:italic>\n                      and evaluated their antimicrobial responsiveness to amoxicillin and alternative clinically relevant antibiotics, including sequential exposure following initial amoxicillin treatment, in an in vitro model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Biofilm formation was quantitatively evaluated using the crystal violet staining method with a 96-well pin replicator. Twenty clinical isolates of\n                      <jats:italic>M. catarrhalis<\/jats:italic>\n                      were first cultured for 24\u00a0h to assess their biofilm-forming capacities, which varied considerably among strains, with some producing robust biofilms. To further examine interspecies interactions,\n                      <jats:italic>M. catarrhalis<\/jats:italic>\n                      and NTHi were co-cultured at different CFU ratios, revealing that increasing the proportion of\n                      <jats:italic>M. catarrhalis<\/jats:italic>\n                      in the inoculum enhanced overall biofilm production compared with either species alone. Additionally, exposure to selected antibiotics showed that respiratory quinolones were associated with greater reductions in biofilm biomass and viable bacteria within co-culture-derived biofilms compared with amoxicillin, both during direct treatment and following prior amoxicillin exposure, under the experimental conditions tested.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Co-culture of NTHi and\n                      <jats:italic>M. catarrhalis<\/jats:italic>\n                      was shown to significantly enhance biofilm formation compared with either culture species alone. In particular, a higher proportion of\n                      <jats:italic>M. catarrhalis<\/jats:italic>\n                      was associated with increased biofilm production. These findings suggest that polymicrobial coexistence may contribute to reduced antimicrobial responsiveness through enhanced biofilm formation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-026-05420-x","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:34:40Z","timestamp":1784183680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic biofilm formation by the coexistence of nontypeable Haemophilus influenzae and Moraxella catarrhalis reduces amoxicillin efficacy"],"prefix":"10.1186","volume":"26","author":[{"given":"Nafisa Khamis","family":"Umar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Fujishiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kamiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Sakatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Mizobata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Tamagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneki","family":"Hotomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7896-4892","authenticated-orcid":false,"given":"Masamitsu","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"9","key":"5420_CR1","doi-asserted-by":"publisher","first-page":"e000214","DOI":"10.1099\/mgen.0.000214","volume":"4","author":"E Heinz","year":"2018","unstructured":"Heinz E. The return of Pfeiffer\u2019s bacillus: Rising incidence of ampicillin resistance in Haemophilus influenzae. Microb Genom. 2018;4(9):e000214. https:\/\/doi.org\/10.1099\/mgen.0.000214.","journal-title":"Microb Genom"},{"issue":"1","key":"5420_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/jac\/dkp401","volume":"65","author":"MA Khan","year":"2010","unstructured":"Khan MA, Northwood JB, Levy F, Verhaegh SJ, Farrell DJ, Van Belkum A, et al. bro \u00df-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults. J Antimicrob Chemother. 2010;65(1):91\u20137. https:\/\/doi.org\/10.1093\/jac\/dkp401.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"5420_CR3","doi-asserted-by":"publisher","first-page":"e0257921","DOI":"10.1128\/spectrum.02579-21","volume":"10","author":"CC Potts","year":"2022","unstructured":"Potts CC, Rodriguez-Rivera LD, Retchless AC, Buono SA, Chen AT, Marjuki H, Blain AE, Wang X. Antimicrobial susceptibility survey of invasive Haemophilus influenzae in the United States in 2016. Microbiol Spectr. 2022;10(3):e0257921. https:\/\/doi.org\/10.1128\/spectrum.02579-21.","journal-title":"Microbiol Spectr"},{"issue":"9","key":"5420_CR4","doi-asserted-by":"publisher","first-page":"e00851","DOI":"10.1128\/AAC.00851-18","volume":"62","author":"H Honda","year":"2018","unstructured":"Honda H, Sato T, Shinagawa M, Fukushima Y, Nakajima C, Suzuki Y, Shiraishi T, Kuronuma K, Takahashi S, Takahashi H, Yokota SI. Multiclonal expansion and high prevalence of beta-lactamase-negative Haemophilus influenzae with high-level ampicillin resistance in Japan and susceptibility to quinolones. Antimicrob Agents Chemother. 2018;62(9):e00851\u201318. https:\/\/doi.org\/10.1128\/AAC.00851-18.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5420_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/jac\/dki281","volume":"56","author":"DJ Farrell","year":"2005","unstructured":"Farrell DJ, Morrissey I, Bakker S, Buckridge S, Felmingham D. Global distribution of TEM-1 and ROB-1 beta-lactamases in Haemophilus influenzae. J Antimicrob Chemother. 2005;56(4):773\u20136. https:\/\/doi.org\/10.1093\/jac\/dki281.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"5420_CR6","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1128\/AAC.45.6.1693-1699.2001","volume":"45","author":"K Ubukata","year":"2001","unstructured":"Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, et al. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother. 2001;45(6):1693\u20139. https:\/\/doi.org\/10.1128\/AAC.45.6.1693-1699.2001.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5420_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1128\/CMR.15.1.125-144.2002","volume":"15","author":"CM Verduin","year":"2002","unstructured":"Verduin CM, Hol C, Fleer A, van Dijk H, van Belkum A. Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev. 2002;15(1):125\u201344. https:\/\/doi.org\/10.1128\/CMR.15.1.125-144.2002.","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"5420_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41579-022-00767-0","volume":"20","author":"K Sauer","year":"2022","unstructured":"Sauer K, Stoodley P, Goeres DM, Hall-Stoodley L, Burm\u00f8lle M, Stewart PS, et al. The biofilm life cycle: expanding the conceptual model of biofilm formation. Nat Rev Microbiol. 2022;20(10):608\u201320. https:\/\/doi.org\/10.1038\/s41579-022-00767-0.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"5420_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41579-022-00791-0","volume":"21","author":"HC Flemming","year":"2023","unstructured":"Flemming HC, van Hullebusch ED, Neu TR, Nielsen PH, Seviour T, Stoodley P, et al. The biofilm matrix: multitasking in a shared space. Nat Rev Microbiol. 2023;21(2):70\u201386. https:\/\/doi.org\/10.1038\/s41579-022-00791-0.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"5420_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.prrv.2012.03.001","volume":"13","author":"LO Bakaletz","year":"2012","unstructured":"Bakaletz LO. Bacterial biofilms in the upper airway - evidence for role in pathology and implications for treatment of otitis media. Paediatr Respir Rev. 2012;13(3):154\u20139. https:\/\/doi.org\/10.1016\/j.prrv.2012.03.001.","journal-title":"Paediatr Respir Rev"},{"issue":"23","key":"5420_CR11","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1016\/j.cell.2021.10.010","volume":"184","author":"JR Buzzo","year":"2021","unstructured":"Buzzo JR, Devaraj A, Gloag ES, Jurcisek JA, Robledo-Avila F, Kesler T, et al. Z-form extracellular DNA is a structural component of the bacterial biofilm matrix. Cell. 2021;184(23):5740\u2013e575817. https:\/\/doi.org\/10.1016\/j.cell.2021.10.010.","journal-title":"Cell"},{"issue":"2","key":"5420_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-0038-1660818","volume":"14","author":"LA Novotny","year":"2019","unstructured":"Novotny LA, Brockman KL, Mokrzan EM, Jurcisek JA, Bakaletz LO. Biofilm biology and vaccine strategies for otitis media due to nontypeable Haemophilus influenzae. J Pediatr Infect Dis. 2019;14(2):69\u201377. https:\/\/doi.org\/10.1055\/s-0038-1660818.","journal-title":"J Pediatr Infect Dis"},{"key":"5420_CR13","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.2147\/IDR.S424468","volume":"16","author":"J Xiao","year":"2023","unstructured":"Xiao J, Su L, Huang S, Liu L, Ali K, Chen Z. Epidemic trends and biofilm formation mechanisms of Haemophilus influenzae: Insights into clinical implications and prevention strategies. Infect Drug Resist. 2023;16:5359\u201373. https:\/\/doi.org\/10.2147\/IDR.S424468.","journal-title":"Infect Drug Resist"},{"issue":"12","key":"5420_CR14","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.jiac.2022.07.019","volume":"28","author":"NK Umar","year":"2022","unstructured":"Umar NK, Kono M, Sakatani H, Murakami D, Onishi Y, Kamiyama T, et al. Respiratory quinolones can eradicate amoxicillin-induced mature biofilms and nontypeable Haemophilus influenzae in biofilms. J Infect Chemother. 2022;28(12):1595\u2013604.","journal-title":"J Infect Chemother"},{"issue":"9","key":"5420_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/00006454-200009000-00034","volume":"19","author":"ME Pichichero","year":"2000","unstructured":"Pichichero ME. Recurrent and persistent otitis media. Pediatr Infect Dis J. 2000;19(9):911\u20136.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"5420_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/01.inf.0000066798.69778.07","volume":"22","author":"E Leibovitz","year":"2003","unstructured":"Leibovitz E, Greenberg D, Piglansky L, Raiz S, Porat N, Press J, et al. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Pediatr Infect Dis J. 2003;22(3):209\u201316.","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"5420_CR17","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1086\/429918","volume":"191","author":"S Libson","year":"2005","unstructured":"Libson S, Dagan R, Greenberg D, Porat N, Trepler R, Leiberman A, et al. Nasopharyngeal carriage of Streptococcus pneumoniae at the completion of successful antibiotic treatment of acute otitis media predisposes to early clinical recurrence. J Infect Dis. 2005;191(11):1869\u201375.","journal-title":"J Infect Dis"},{"issue":"4","key":"5420_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/INF.0b013e31815ed79c","volume":"27","author":"E Asher","year":"2008","unstructured":"Asher E, Dagan R, Greenberg D, Givon-Lavi N, Libson S, Porat N, et al. Persistence of pathogens despite clinical improvement in antibiotic-treated acute otitis media is associated with clinical and bacteriologic relapse. Pediatr Infect Dis J. 2008;27(4):296\u2013301.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"5420_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/INF.0b013e31815c1b1d","volume":"27","author":"R Dagan","year":"2008","unstructured":"Dagan R, Schneider S, Givon-Lavi N, Greenberg D, Leiberman A, Jacobs MR, et al. Failure to achieve early bacterial eradication increases clinical failure rate in acute otitis media in young children. Pediatr Infect Dis J. 2008;27(3):200\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"5420_CR20","doi-asserted-by":"publisher","first-page":"100096","DOI":"10.1016\/j.bioflm.2022.100096","volume":"4","author":"JA Jurcisek","year":"2022","unstructured":"Jurcisek JA, Hofer LK, Goodman SD, Bakaletz LO. Monoclonal antibodies that target extracellular DNABII proteins or the type IV pilus of nontypeable Haemophilus influenzae (NTHI) worked additively to disrupt 2-genera biofilms. Biofilm. 2022;4:100096. https:\/\/doi.org\/10.1016\/j.bioflm.2022.100096.","journal-title":"Biofilm"},{"issue":"3","key":"5420_CR21","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1128\/IAI.74.3.1588-1596.2006","volume":"74","author":"MM Pearson","year":"2006","unstructured":"Pearson MM, Laurence CA, Guinn SE, Hansen EJ. Biofilm formation by Moraxella catarrhalis in vitro: roles of the UspA1 adhesin and the Hag hemagglutinin. Infect Immun. 2006;74(3):1588\u201396. https:\/\/doi.org\/10.1128\/IAI.74.3.1588-1596.2006.","journal-title":"Infect Immun"},{"issue":"12","key":"5420_CR22","doi-asserted-by":"publisher","first-page":"5559","DOI":"10.1128\/IAI.00946-07","volume":"75","author":"NR Luke","year":"2007","unstructured":"Luke NR, Jurcisek JA, Bakaletz LO, Campagnari AA. Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation. Infect Immun. 2007;75(12):5559\u201364. https:\/\/doi.org\/10.1128\/IAI.00946-07.","journal-title":"Infect Immun"},{"issue":"4","key":"5420_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/INF.0b013e3181c1bc48","volume":"29","author":"JR Casey","year":"2010","unstructured":"Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010;29(4):304\u20139.","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"5420_CR24","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1086\/647933","volume":"49","author":"A Broides","year":"2009","unstructured":"Broides A, Dagan R, Greenberg D, Givon-Lavi N, Leibovitz E. Acute otitis media caused by Moraxella catarrhalis: epidemiologic and clinical characteristics. Clin Infect Dis. 2009;49(11):1641\u20137.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"5420_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s10156-013-0592-y","volume":"19","author":"S Takei","year":"2013","unstructured":"Takei S, Hotomi M, Yamanaka N. Minimal biofilm eradication concentration of antimicrobial agents against nontypeable Haemophilus influenzae isolated from middle ear fluids of intractable acute otitis media. J Infect Chemother. 2013;19(3):504\u20139.","journal-title":"J Infect Chemother"},{"issue":"5","key":"5420_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.anl.2008.10.010","volume":"36","author":"S Moriyama","year":"2009","unstructured":"Moriyama S, Hotomi M, Shimada J, Billal DS, Fujihara K, Yamanaka N. Formation of biofilm by Haemophilus influenzae isolated from pediatric intractable otitis media. Auris Nasus Larynx. 2009;36(5):525\u201331.","journal-title":"Auris Nasus Larynx"},{"key":"5420_CR27","doi-asserted-by":"publisher","unstructured":"Pierce CG, Uppuluri P, Tummala S, Lopez-Ribot JL. A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms. J Vis Exp. 2010;(44):2287. https:\/\/doi.org\/10.3791\/2287. PMID: 21048668; PMCID: PMC3185615.","DOI":"10.3791\/2287"},{"key":"5420_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.mi.41.100187.002251","volume":"41","author":"JW Costerton","year":"1987","unstructured":"Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol. 1987;41:435\u201364.","journal-title":"Annu Rev Microbiol"},{"issue":"3","key":"5420_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1046\/j.1365-2958.1998.00797.x","volume":"28","author":"GA O\u2019Toole","year":"1998","unstructured":"O\u2019Toole GA, Kolter R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol. 1998;28(3):449\u201361.","journal-title":"Mol Microbiol"},{"key":"5420_CR30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7164\/antibiotics.46.1173","volume":"46","author":"R Fujii","year":"1993","unstructured":"Fujii R, Yoshioka H, Okuno A, Fujita K, Murono K, Maruyama S, et al. Pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field. Pediatric Study Group of ME1207. Jpn J Antibiot. 1993;46:95\u2013114.","journal-title":"Jpn J Antibiot"},{"issue":"5","key":"5420_CR31","first-page":"309","volume":"69","author":"N Yamanaka","year":"2016","unstructured":"Yamanaka N, Hotomi M. Bactericidal effect of tosufloxacin on Haemophilus influenzae internalized in cultured human cells. Jpn J Antibiot. 2016;69(5):309\u201318.","journal-title":"Jpn J Antibiot"},{"key":"5420_CR32","first-page":"194","volume":"55","author":"S Baba","year":"2007","unstructured":"Baba S, Suzuki K, Yamanaka N, Yajin K. Clinical phase III open-label study of oral Garenoxacin in patients with otorhinolaryngological infection. Jpn J Chemother. 2007;55:194\u2013205.","journal-title":"Jpn J Chemother"},{"key":"5420_CR33","first-page":"1830","volume":"21","author":"T Iwasawa","year":"1973","unstructured":"Iwasawa T. The fundamental and clinical studies on amoxycillin in the otorhinolaryngologic field. Chemotherapy. 1973;21:1830\u20137.","journal-title":"Chemotherapy"},{"key":"5420_CR34","unstructured":"Wilson C, Lukowicz R, Merchant S, Valquier-Flynn H, Caballero J, Sandoval J et al. Quantitative and qualitative assessment methods for biofilm growth: a mini-review. Res Rev J Eng Technol. 2017;6(4):http:\/\/www.rroij.com\/open-access\/quantitative-and-qualitative-assessment-methods-for-biofilm-growth-a-minireview-.pdf. Epub 2017 Oct 24. PMID: 30214915; PMCID: PMC6133255. http:\/\/www.rroij.com\/open-access\/quantitative-and-qualitative-assessment-methods-for-biofilm-growth-a-minireview-.pdf."},{"key":"5420_CR35","doi-asserted-by":"publisher","unstructured":"O\u2019Toole GA. Microtiter dish biofilm formation assay. J Vis Exp. 2011;(47):2437. https:\/\/doi.org\/10.3791\/2437. PMID: 21307833; PMCID: PMC3182663.","DOI":"10.3791\/2437"},{"issue":"9","key":"5420_CR36","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrmicro2415","volume":"8","author":"HC Flemming","year":"2010","unstructured":"Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8(9):623\u201333.","journal-title":"Nat Rev Microbiol"},{"key":"5420_CR37","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.3389\/fmicb.2019.03006","volume":"10","author":"KL Bair","year":"2019","unstructured":"Bair KL, Campagnari AA. Moraxella catarrhalis promotes stable polymicrobial biofilms with the major otopathogens. Front Microbiol. 2019;10:3006.","journal-title":"Front Microbiol"},{"issue":"2","key":"5420_CR38","doi-asserted-by":"publisher","first-page":"e01992","DOI":"10.1128\/AAC.01992-16","volume":"61","author":"M Domenech","year":"2017","unstructured":"Domenech M, Garc\u00eda E. N-Acetyl-l-Cysteine and Cysteamine as New Strategies against Mixed Biofilms of Nonencapsulated Streptococcus pneumoniae and Nontypeable Haemophilus influenzae. Antimicrob Agents Chemother. 2017;61(2):e01992\u201316. https:\/\/doi.org\/10.1128\/AAC.01992-16.","journal-title":"Antimicrob Agents Chemother"},{"key":"5420_CR39","doi-asserted-by":"publisher","unstructured":"Mokrzan EM, Novotny LA, Brockman KL, Bakaletz LO. Antibodies against the majority subunit (PilA) of the type IV pilus of nontypeable Haemophilus influenzae disperse Moraxella catarrhalis from a dual-species biofilm. mBio. 2018;9(6):e02423\u201318. https:\/\/doi.org\/10.1128\/mBio.02423-18. PMID: 30538189; PMCID: PMC6299487.","DOI":"10.1128\/mBio.02423-18"},{"key":"5420_CR40","doi-asserted-by":"publisher","unstructured":"Armbruster CE, Hong W, Pang B, Weimer KE, Juneau RA, Turner J et al. Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. mBio. 2010;1(3):e00102\u201310. https:\/\/doi.org\/10.1128\/mBio.00102-10. PMID: 20802829; PMCID: PMC2925075.","DOI":"10.1128\/mBio.00102-10"},{"issue":"12","key":"5420_CR41","doi-asserted-by":"publisher","first-page":"e00506","DOI":"10.1128\/IAI.00506-18","volume":"86","author":"B Pang","year":"2018","unstructured":"Pang B, Armbruster CE, Foster G, Learman BS, Gandhi U, Swords WE. Autoinducer 2 (AI-2) Production by nontypeable Haemophilus influenzae 86-028NP promotes expression of a predicted glycosyltransferase that is a determinant of biofilm maturation, prevention of dispersal, and persistence in Vivo. Infect Immun. 2018;86(12):e00506\u201318. https:\/\/doi.org\/10.1128\/IAI.00506-18.","journal-title":"Infect Immun"},{"issue":"7","key":"5420_CR42","doi-asserted-by":"publisher","first-page":"e99204","DOI":"10.1371\/journal.pone.0099204","volume":"9","author":"S Wu","year":"2014","unstructured":"Wu S, Li X, Gunawardana M, Maguire K, Guerrero-Given D, Schaudinn C, et al. Beta-lactam antibiotics stimulate biofilm formation in non-typeable Haemophilus influenzae by up-regulating carbohydrate metabolism. PLoS ONE. 2014;9(7):e99204.","journal-title":"PLoS ONE"},{"issue":"8","key":"5420_CR43","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1128\/AAC.01772-10","volume":"55","author":"V Schaar","year":"2011","unstructured":"Schaar V, Nordstr\u00f6m T, M\u00f6rgelin M, Riesbeck K. Moraxella catarrhalis outer membrane vesicles carry \u03b2-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrob Agents Chemother. 2011;55(8):3845\u201353. https:\/\/doi.org\/10.1128\/AAC.01772-10.","journal-title":"Antimicrob Agents Chemother"},{"key":"5420_CR44","doi-asserted-by":"publisher","unstructured":"Hiraoka M, Sugita G, Gunduz M, Gunduz E, Tamagawa S, Kono M, et al. Tosufloxacin for eradicating biofilm-forming nontypeable Haemophilus influenzae isolated from intractable acute otitis media. Jundishapur J Microbiol. 2019;12(3):e69583. https:\/\/doi.org\/10.5812\/jjm.69583.","DOI":"10.5812\/jjm.69583"},{"issue":"1","key":"5420_CR45","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1186\/s12879-025-11438-9","volume":"25","author":"MM Sfeir","year":"2025","unstructured":"Sfeir MM. Haemophilus influenzae global epidemiology and antimicrobial susceptibility patterns including ampicillin and amoxicillin-clavulanate resistance based on beta-lactamase production, 2013\u20132022. BMC Infect Dis. 2025;25(1):1391. https:\/\/doi.org\/10.1186\/s12879-025-11438-9.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"5420_CR46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12879-023-08930-5","volume":"24","author":"M Abavisani","year":"2024","unstructured":"Abavisani M, Keikha M, Karbalaei M. First global report about the prevalence of multi-drug resistant Haemophilus influenzae: a systematic review and meta-analysis. BMC Infect Dis. 2024;24(1):90. https:\/\/doi.org\/10.1186\/s12879-023-08930-5.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"5420_CR47","doi-asserted-by":"publisher","first-page":"102812","DOI":"10.1016\/j.jiac.2025.102812","volume":"31","author":"N Ishiwada","year":"2025","unstructured":"Ishiwada N, Nishi J, Fujimaki K, Takahashi S, Matsumoto T, Sato J, et al. Nationwide surveillance of bacterial pathogens isolated from children by the surveillance committee of the Japanese society of chemotherapy, Japanese association for infectious diseases, and Japanese society for clinical microbiology between April 2021 and March 2024: General overview of pathogenic antimicrobial susceptibility. J Infect Chemother. 2025;31(10):102812. https:\/\/doi.org\/10.1016\/j.jiac.2025.102812.","journal-title":"J Infect Chemother"},{"issue":"10","key":"5420_CR48","doi-asserted-by":"publisher","first-page":"102781","DOI":"10.1016\/j.jiac.2025.102781","volume":"31","author":"I Tokimatsu","year":"2025","unstructured":"Tokimatsu I, Fujikura Y, Matsumoto T, Tsukada H, Miki M, Morinaga Y, et al. Nationwide surveillance of antibacterial susceptibility in bacterial respiratory pathogens in Japan, 2022\u20132023. J Infect Chemother. 2025;31(10):102781. https:\/\/doi.org\/10.1016\/j.jiac.2025.102781.","journal-title":"J Infect Chemother"},{"issue":"23","key":"5420_CR49","doi-asserted-by":"publisher","first-page":"6746","DOI":"10.1128\/JB.183.23.6746-6751.2001","volume":"183","author":"AL Spoering","year":"2001","unstructured":"Spoering AL, Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol. 2001;183(23):6746\u201351.","journal-title":"J Bacteriol"},{"issue":"2","key":"5420_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1620\/tjem.214.121","volume":"214","author":"C Kaji","year":"2008","unstructured":"Kaji C, Watanabe K, Apicella MA, Watanabe H. Antimicrobial effect of fluoroquinolones for the eradication of nontypeable Haemophilus influenzae isolates within biofilms. Tohoku J Exp Med. 2008;214(2):121\u20138.","journal-title":"Tohoku J Exp Med"},{"issue":"3","key":"5420_CR51","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10156-012-0502-8","volume":"19","author":"M Takahata","year":"2013","unstructured":"Takahata M, Sugiura Y, Shinmura Y, Fukuda Y, Nomura N. Bactericidal activity of garenoxacin against in vitro biofilm formed by nontypeable Haemophilus influenzae. J Infect Chemother. 2013;19(3):441\u20136.","journal-title":"J Infect Chemother"},{"issue":"5","key":"5420_CR52","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s10156-013-0598-5","volume":"19","author":"Y Uemura","year":"2013","unstructured":"Uemura Y, Qin L, Gotoh K, Ohta K, Nakamura K, Watanabe H. Comparison study of single and concurrent administrations of carbapenem, new quinolone, and macrolide against in vitro nontypeable Haemophilus influenzae mature biofilms. J Infect Chemother. 2013;19(5):902\u20138.","journal-title":"J Infect Chemother"},{"key":"5420_CR53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fcimb.2020.00213","volume":"10","author":"AL Welp","year":"2020","unstructured":"Welp AL, Bomberger JM. Bacterial community interactions during chronic respiratory disease. Front Cell Infect Microbiol. 2020;10:213. https:\/\/doi.org\/10.3389\/fcimb.2020.00213.","journal-title":"Front Cell Infect Microbiol"},{"key":"5420_CR54","doi-asserted-by":"publisher","first-page":"107650","DOI":"10.1016\/j.micpath.2025.107650","volume":"205","author":"J Xiao","year":"2025","unstructured":"Xiao J, Su L, Huang S, Zhou M, Chen Z. Integrated transcriptomics and metabolomics study on the biofilm formation of Haemophilus influenzae by the stimulation of amoxicillin-clavulanate at subinhibitory concentration. Microb Pathog. 2025;205:107650.","journal-title":"Microb Pathog"},{"key":"5420_CR55","doi-asserted-by":"publisher","first-page":"36424","DOI":"10.1038\/srep36424","volume":"6","author":"M Domenech","year":"2016","unstructured":"Domenech M, Pedrero-Vega E, Prieto A, Garc\u00eda E. Evidence of the presence of nucleic acids and beta-glucan in the matrix of non-typeable Haemophilus influenzae in vitro biofilms. Sci Rep. 2016;6:36424. https:\/\/doi.org\/10.1038\/srep36424.","journal-title":"Sci Rep"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05420-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05420-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05420-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:49:08Z","timestamp":1791758948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05420-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5420"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05420-x","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study did not involve human participants, human data, or human tissue.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported by FUJIFILM Toyama Chemical Co., Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no other competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"877"}}